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Human herpesvirus 6 (HHV-6) is a T-lymphotropic virus belonging to the betaherpesvirus family.
Several HHV-6-encoded glycoproteins are required for cell entry and virion maturation. Glycoprotein M
(gM) is conserved among all herpesviruses, and therefore thought to have important functions;
however, the HHV-6 g has not been characterized. Here, we examined the expression of HHV-6 g, and
examined its function in viral replication, using a mutant and revertant gM. HHV-6 g was expressed
on virions as a glycoprotein modiﬁed with complex N-linked oligosaccharides. As in other herpesviruses,
HHV-6 g formed a complex with glycoprotein N (gN), and was transported from the endoplasmic reticulum
to the trans-Golgi network only when part of this complex. Finally, a gMmutant virus in which the gM start
codon was destroyed was not reconstituted, although its revertant was, indicating that HHV-6 g is essential
for virus production, unlike the gM of alphaherpesviruses.
& 2012 Elsevier Inc. All rights reserved.Introduction
Human herpesvirus 6 (HHV-6) is a betaherpesvirus related to
human herpesvirus 7 (HHV-7) and human cytomegalovirus
(HCMV) and is a human pathogen of emerging clinical signiﬁ-
cance. HHV-6 was ﬁrst isolated from the peripheral blood lym-
phocytes of patients with lymphoproliferative disorders and
acquired immunodeﬁciency syndrome (Salahuddin et al., 1986).
HHV-6 is categorized as two variants, A (HHV-6A) and B (HHV-6B),
on the basis of its in vitro growth properties, DNA restriction site
polymorphisms, antigenicity, and host cell tropism (Ablashi et al.,
1991; Aubin et al., 1991; Campadelli-Fiume et al., 1993; Chandran
et al., 1992). HHV-6B is the causative agent of exanthem subitum
(Yamanishi et al., 1988), but the role of HHV-6A in human disease is
less clear.
Herpesviruses encode a number of glycoproteins that are present
in the envelope of the virion and play important roles in viral
infection, including attachment, penetration, cell-to-cell spread,
envelopment, and the maturation of nascent viral particles. The
genomes of herpesviruses contain a number of genes that are
conserved throughout the family Herpesviridae, including those
encoding glycoprotein (g) B, gH, gL, gM, and gN. Although these
genes are conserved, the corresponding proteins appear to havell rights reserved.
logy, Kobe University
Chuo-ku, Kobe 650-0017,
@nibio.go.jp (Y. Mori).different functional roles in the replication of herpesviruses from
different subgroups. For example, gM is reported to be non-essential
for the replication of alphaherpesviruses, including herpes simplex
virus type-1 (HSV-1) (Baines and Roizman, 1991; MacLean et al.,
1993), pseudorabies virus (PRV) (Dijkstra et al., 1996), bovine
herpesvirus type-1 (Konig et al., 2002), varicella-zoster virus (VZV)
(Yamagishi et al., 2008), infectious laryngotracheitis virus (Fuchs and
Mettenleiter, 1999), equine herpesvirus type-1 (EHV-1) (Osterrieder
et al., 1997), and EHV-4 (Ziegler et al., 2005). However, the gMs of
HCMV, murine gammaherpesvirus 68 and Marek’s disease virus are
essential for the production of infectious virus (Hobom et al., 2000;
May et al., 2005; Tischer et al., 2002).
The gM protein has multiple transmembrane domains and
N-linked glycosylation sites, forms a disulﬁde-linked complex
with gN (Jons et al., 1998; Koyano et al., 2003; Mach et al.,
2000; Wu et al., 1998), and functions mainly in virion assembly
and egress (Brack et al., 1999; Krzyzaniak et al., 2007; Lake
and Hutt-Fletcher, 2000; Mettenleiter et al., 2009; Rudolph and
Osterrieder, 2002). Consistent with these roles, co-transfected gM
and gN colocalize in the trans-Golgi network (TGN) and endoso-
mal compartment (Mach et al., 2000; May et al., 2005;
Mettenleiter et al., 2009), where herpesvirus secondary envelop-
ment occurs (Mettenleiter et al., 2009). The formation of the
gM–gN complex is required for gM’s transport from the endo-
plasmic reticulum (ER) to the TGN and endosomal compartment
(Krzyzaniak et al., 2007; Mach et al., 2000). Recently, antibodies
against the gM–gN complex were shown to have a neutralizing
function in HCMV infection (Shimamura et al., 2006). These
Fig. 1. Predicted topology of HHV-6A gM. The topology of HHV-6A gM was
predicted using the TMHMM transmembrane topology prediction server (http://
www.cbs.dtu.dk/services/TMHMM/). The approximate location of two N-linked
glycosylation sites (NKT, asparagine-lysine-threonine; NQT, asparagine-gluta-
mine-threonine) is indicated.
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virus entry into host cells.
The gM cytoplasmic tail contains several trafﬁcking motifs that
are conserved in alpha-, beta-, and gamma-herpesviruses have
important functions. These include YXXF motifs, which have
been linked to AP2 binding (Owen and Evans, 1998), and an
acidic cluster, which may be involved in TGN targeting (Voorhees
et al., 1995). Removal of a YXXF motif in the cytoplasmic tail of
the MuHV-4 gM prevents the virus’s productive replication (May
et al., 2008). The replication of HCMV is also blocked by the
deletion or mutation of the gM carboxy-terminal cytoplasmic tail
sequence (Krzyzaniak et al., 2007). In addition, the HCMV gM
cytoplasmic tail was shown to interact with a cellular component,
the Rab11 effector protein FIP4 (family of interacting protein 4)
(Krzyzaniak et al., 2009). The HSV-1 gM may play similar roles
in viral replication, because both gD and gH/gL are efﬁciently
internalized and targeted to intracellular compartments when co-
expressed with gM (Crump et al., 2004), and gM is important for
the assembly of infectious HSV-1, due to its ability to control the
localization of gH/gL (Ren et al., 2011). However, the detailed
functions of HHV-6 g during virus infection are still unknown.
HHV-6 gM is a product of the U72 ORF, and composed of 343
amino acids. It is predicted to be a type III glycoprotein and is
composed with seven membrane-spanning domains. The gM of
HSV-1 and VZV is reported to colocalize with a marker for the
Golgi apparatus and to partially colocalize with a marker for the
TGN in infected cells (Baines et al., 2007; Yamagishi et al., 2008).
We found that HHV-6A gM is expressed on the TGN, late
endosomes, and multivesicular bodies (MVBs) in infected cells
(Mori et al., 2008), suggesting that HHV-6 gM may be involved in
virus assembly, virion maturation, and egress.
We report here that HHV-6 gM was incorporated into mature
virus particles with complex N-linked oligosaccharides and that it
associated with a product of the U46 ORF, the herpesvirus gN
homolog, and that this interaction was critical for gM’s trafﬁcking.
Furthermore, we found that gM was essential for virus produc-
tion, in contrast to the gM of many alphaherpesviruses.Fig. 2. Expression of gM in HHV-6A-infected cells and virions. HHV-6A-infected
or mock-infected HSB-2 cells were harvested at 96 h postinfection. The lysates of
HHV-6A-infected or mock-infected HSB-2 cells, or of puriﬁed virions were
analyzed by western blotting. The blots were reacted with an anti-gM Mab. The
cells were harvested at 96 h postinfection and lysed. The numbers beside the
panels show molecular masses. White arrow indicates the 24 kDa gM. Black arrow
indicates the 15 kDa gM. WB, Western blotting.Results
Characterization of HHV-6A gM in infected cells and puriﬁed virions
To analyze the expression of HHV-6A gM in infected cells,
GS-infected cells were harvested at 96 h postinfection, lysed, and
subjected to western blotting with an anti-gM Mab. In infected
cells, the gM was detected as a multiple-band smear extending
from approximately 36–52 kDa, below which were two well-
demarcated single bands, at 15 and 24 kDa (Fig. 2).
Puriﬁed virions were also subjected to western blotting with
the anti-gM Mab. Interestingly, in the puriﬁed virions, gM was
detected as broad multiple bands from 34 to 75 kDa, but the
smaller bands of 15–24 kDa, found in the infected cells, were not
detected. These results showed that HHV-6A gM, like the gM of
other herpesviruses, is a component of the virions.
HHV-6A gM was predicted to be a type III membrane protein
that possesses seven transmembrane domains and has two
potential N-linked glycosylation sites at the putative second
extracellular loop (Fig. 1; TMHMM prediction server; http://
www.cbs.dtu.dk/services/TMHMM/). Given the broad multiple
bands detected in both infected cells and virions, as described
above, we examined gM’s glycosylation state in HHV-6A-infected
cells and in puriﬁed virions, by treating the lysates with two kinds
of endoglycosidase, endo H and PNGase F. The digested proteins
were analyzed by western blotting with an anti-gM Ab. The gM in
both infected cells and virions was resistant to endo H treatment,and showed no shift in its electrophoretic mobility (Fig. 3(a). After
PNGase F digestion, however, the broad bands of gM were shifted
to approximately 30 kDa in both infected cells and virions
(Fig. 3(b)), but the smaller bands found in the infected cells were
not changed. These results indicated that HHV-6A gM was
glycosylated with complex N-linked oligosaccharides and incor-
porated into virions as an envelope glycoprotein.
To conﬁrm that HHV-6A gM behaves as a late protein, the
timing of its presence in infected cells was examined by PFA
treatment (Fig. 4). GS-infected HSB-2 cells were maintained for
48 h in culture medium with or without PFA. As shown in Fig. 4,
neither gM nor the late protein gQ1 was detected in cells treated
Fig. 3. Glycosidase digestion patterns of HHV-6A-infected HSB-2 cells and puriﬁed virions. The lysates were digested with endo H (a) or PNGase F (b) and analyzed by
western blotting. The blots were reacted with an anti-gM Ab or anti- gQ1 (AgQ1-119) (c) as positive control of endo H digestion. The cells were lysed with TNE buffer at
96 h postinfection. The numbers beside the panels show molecular masses. WB, Western blotting.
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protein U27 were detected in the PFA-treated cells in both
infected cells and virions. These results indicate that gM belongs
to the late class of HHV-6A proteins.
Complex formation of HHV-6A gM and gN
Generally, gM has been reported to form a complex with gN
(Jons et al., 1998; Mach et al., 2000, 2005). Therefore, to examine
if HHV-6 g also binds gN, 293T cells were cotransfected with
HA-AgM and AgN-FLAG (Fig. 5(A)). The cells were harvested at 72 h
post transfection, lysed, and subjected to western blotting with an
anti-gM or anti-FLAG Ab. When 293T cells were transfected with a
plasmid expressing gM alone, gM was detected as broad multiple
bands of 47–63 kDa and 28–35 kDa (lane 2 of upper panel in
Fig. 5(B-a)). However, when 293T cells were cotransfected with
plasmids expressing gM and gN, the size distribution of the multiple
gM bands changed (lane 1 of upper panel in Fig. 5(B-a)). These
results indicate that HHV-6A gM was modiﬁed in the presence
of gN. In contrast, HHV-6A gN was detected as a 13 kDa band
regardless of gM expression (lower panel in Fig. 5(B-a)).
The lysates from cells co-expressing HA-AgM and AgN-FLAG
were then immunoprecipitated with an anti-HA Ab for gM or
anti-FLAG Ab for gN, followed by western blotting with an anti-
gM Ab or anti-FLAG Ab (Fig. 5(B-b)). When gM or gN was
expressed alone, the anti-HA Ab precipitated only gM (lane 2 in
Fig. 5(B-b)) and the anti-FLAG Ab precipitated only gN (lane 4
in Fig. 5(B-b)), as expected. However, in the lysates of gM- and
gN-coexpressing cells, the anti-HA Ab precipitated both gM (lane1 of upper panel in Fig. 5(B-b)) and gN (lane 1 of lower panel in
Fig. 5(B-b)), and the anti-FLAG Ab also precipitated both gM (lane
3 of upper panel in Fig. 5(B-b)) and gN (lane 3 of lower panel in
Fig. 5(B-b)). These results indicated that the HHV-6A gM and gN
formed a complex in the absence of any other viral factors, and
that gN was required for the efﬁcient modiﬁcations of gM.
Transportation of HHV-6A gM and gN
To conﬁrm that gM formed a complex with gN and to deﬁne
the intracellular compartment in which this association occurred,
we transiently expressed gM and gN or gM alone in 293T cells,
followed by an IFA with antibodies directed against the viral
protein, epitope tag, or markers of the secretary pathway. 293T
cells were cotransfected with HA-AgM and AgN-FLAG or trans-
fected with HA-AgM alone, and the IFA was performed at 72 h
post transfection (Figs. 6 and 7). When HHV-6A gMwas expressed
alone, it partially colocalized with calnexin, a marker of the ER
(Fig. 6(B-a)), but not with TGN46 (Fig. 6(B-b)). In contrast, when
the expression plasmids for gM and gN were cotransfected into
293T cells (Fig. 7), gM colocalized with gN at the TGN. These
results indicated that the formation of a complex of HHV-6A gM
and gN was required for the efﬁcient transport of gM to the distal
compartments of the secretary pathway.
Generation of gM mutant virus and its revertant
It was previously shown using BAC mutagenesis that gM is
essential for the in vitro replication of HCMV (Krzyzaniak et al.,
Fig. 4. IFA of HHV-6A-infected HSB-2 cells with PFA treatment. HSB-2 cells were
infected with HHV-6A in the presence (þ) or absence () of PFA. The cells were
harvested at 48 h postinfection and stained with anti-gM, -IE1, -U27, and -gQ1
antibodies.
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reconstituted the infectious virus (Tang et al., 2010). Therefore,
using the established HHV-6 BAC mutagenesis, we examined
whether HHV-6 gM was essential for virus production. We con-
structed a gM mutant using established methods for BAC muta-
genesis, HHV-6ABACgMM1L in which the start codon of gM was
mutated, and its revertant, HHV-6ABACgMM1Lrev, and conﬁrmed
the mutation by sequencing. We then attempted to reconstitute
infectious virus using these BACs. Infectious viruses could be
reconstituted from HHV-6ABAC and HHV-6ABACgMM1Lrev, but
not from HHV-6ABACgMM1L. We then conﬁrmed the expression
of gM and gQ1 by western blotting using anti-gM antisera and an
anti-gQ1 Mab. As shown in Fig. 8, gM and gQ1 were detected in
the HHV-6ABAC and HHV-6ABACgMM1Lrev reconstituted cell
lysates, but not in those of HHV-6ABACgMM1L. These results
indicate that the HHV-6 g is essential for virus growth.Discussion
In this study, we found that HHV-6A ORF U72 and U46 encode
the gM and gN homologs, respectively, which bind to each other
to form a complex. These results were consistent with previous
descriptions of the gM–gN complex in alpha-, beta- and gamma-
herpesviruses, indicating that the gM–gN protein complex is
conserved throughout the family Herpesviridae.We found that gM was modiﬁed with complex N-linked
oligosaccharides in HHV-6-infected cells, and that its full glyco-
sylation required its expression with gN. Unfortunately, because
we could not produce an antibody to HHV-6 gN, the expression of
gN and its interaction with gM were not conﬁrmed in HHV-6-
infected cells or virions.
Here gM was found to be a virion component that was
detected on western blots as multiple bands in virions and
infected cells. Interestingly, 24 kDa and 15 kDa forms of gM were
also detected in infected cells, but not in puriﬁed virions. These
bands probably represent the carboxyl terminus of gM, because
the antibodies used here recognize its C-terminal end. Although
the functions of these two proteins are unknown, they are
unlikely to be important after viral budding, since they are not
present in virions. Because these bands have not been detected
for the gM of other herpesviruses (Koyano et al., 2003; Mach et al.,
2000; Osterrieder et al., 1997; Yamagishi et al., 2008), the 24 kDa
and 15 kDa gM proteins may have a speciﬁc function for HHV-6.
As shown in Fig. 3(b), the multiple bands of gM showed a shift in
their electrophoretic mobility to approximately 27 kDa after
PNGase F treatment in infected cells and virions. When infected
cell lysates were digested with PNGase F, the gM bands were
shifted to sharp band, probably representing the gradual addition
of glycans to gM and possibly reﬂecting gM’s formation of a
multimeric complex.
When gM was transiently expressed alone, it was retained in
the ER (Fig. 6), whereas its coexpression with gN caused gM to be
transported to more distal sites in the secretory pathway (Fig. 7),
as shown for other herpesviruses (Mach et al., 2000). As shown
Fig. 5(B), the multiple bands of 37–50 kDa and the 15 kDa band of
gM were detected when it was coexpressed with gN, however
they were absent when gM was expressed alone, and the expres-
sion of the 24 kDa band decreased, indicating that the interaction
with gN is important for gM’s processing.
It had been unknown whether HHV-6 gM was needed for
infection. Therefore, we constructed a gM point mutant virus that
does not express gM. Our data showed that without the expres-
sion of gM, no infectious virus could be reconstituted from the
HHV-6ABAC genome, although the revertant virus could be,
indicating that gM was essential for HHV-6 propagation (Fig. 8).
Further analyses of HHV-6 g will be required to elucidate its
roles in infected cells and virions.Materials and methods
Cells and viruses
T-cell lines (HSB-2 and J JHAN cells) were cultured in RPMI-
1640 medium supplemented with 8% fetal bovine serum. Human
embryonic kidney cells (293T cells) were cultured in Dulbecco’s
modiﬁed Eagle’s medium supplemented with 8% fetal bovine
serum. Umbilical cord blood mononuclear cells (CBMCs) were
prepared as described previously (Mori et al., 2003).
The HHV-6A strain GS was propagated and titrated in HSB-2
cells. HHV-6A cell-free virus was prepared as described elsewhere
(Akkapaiboon et al., 2004). Virions were puriﬁed as described
previously (Mori et al., 2008). Brieﬂy, supernatants from infected
cells were used for virion preparation and virions were separated
by 5–50% Histdenz (Sigma) gradient. The virions-containing
fractions were determined by polymerase chain reaction (PCR)
of viral DNA and western blot of virion proteins. Phosphonoformic
acid (PFA), which inhibits viral DNA synthesis, was used to
determine whether gM is an early or late protein. HSB-2 cells
were infected with HHV-6A, cultured in medium with PFA
(300 mg/ml), and harvested at 48 h postinfection.
Fig. 5. Detection of the gM–gN complex in transfected 293T cells. (A) Schematic representations of HA-tagged gM and FLAG-tagged gN. (B) (a) 293T cells were transfected
with plasmids expressing HA-AgM, AgN-FLAG, or with pCAGGS alone as a negative control. The cell lysates were analyzed by western blotting. The blots were reacted with
anti-gM antiserum or an anti-FLAG Ab for gN. The cells were harvested at 72 h post transfection and lysed. (b) The cells were lysed with TNE buffer at 72 h post
transfection. The lysates were immunoprecipitated (IP) with an anti-HA Ab for gM or anti-FLAG Ab for gN and analyzed by western blotting. The blots were reacted with
the anti-gM antiserum or anti-FLAG Ab. The numbers beside the panels show molecular masses. WB, western blotting.
Fig. 6. Subcellular localization of gM in transfected 293T cells. (A) Schematic representation of HA-tagged gM. (B) 293T cells were transfected with HA-AgM. The cells were
harvested at 72 h posttransfection, then ﬁxed and stained for IFA with antibodies against gM, calnexin (a), or TGN46 (b). Costained areas appear yellow in the merged
panel. Scale bars: 10 mm.
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The rabbit monospeciﬁc antibodies (Abs) against HHV-6 gM
were described previously (Mori et al., 2008), and the anti-HHV-6
gMmonoclonal antibody (Mab), named AgM-1, was produced in ourlaboratory. Hybridoma clones producing Mabs against HHV-6 gM
were produced by three immunizations of mouse footpads. The
gM–gN complex coexpressed in 293T cells was used as an antigen
for immunization, and the detailed puriﬁcation method is described
below. The Mab AIE1 against HHV-6A immediate early-1 protein
Fig. 7. Subcellular localization of gM with gN in transfected 293T cells. (A) Schematic representations of HA-tagged gM and FLAG-tagged gN and (B) 293T cells were
transfected with pCAGGS-HA-AgM and pCAGGS-AgN-FLAG. The cells were harvested at 72 h posttransfection and then ﬁxed and stained for IFA with antibodies against
gM, FLAG for gN, and TGN46. Costained areas appear white in the merged panel. Scale bars: 10 mm.
Fig. 8. gM is essential for HHV-6 growth. (A) Schematic representation of the HHV-6A genome and the HHV-6A gM gene region. The HHV-6 genome consists of three
major internal repeat elements (R1, R2, and R3), the origin of replication (oriLyt), and the direct repeats (DRL and DRR). White box indicates the predicted open reading
frame (ORF) encoding gM, numbered from the start (position 1) to the stop (position 1035) codon. The position of the mutated start codon within gM (ATG mutated to TTG)
is indicated at right. (B) Mock- or reconstituted virus-infected CBMC lysates from HHV-6A BAC genomes (HHV-6ABAC [wild type], HHV-6ABACgMM1L [mutant], and
HHV-6ABACgMM1Lrev [revertant]) were subjected to SDS-PAGE, followed by western blotting (WB), and probed with anti-gQ1 or -gM antibodies. Numbers beside the
panels show molecular masses in kilodaltons.
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previously (Huang et al., 2006; Mori et al., 2003). The Mab U27 A42-
1 against the HHV-6 early protein U27 was produced as described
previously (Okuno et al., 1992). The Mab against calnexin (clone:
AF18; Abcam), and sheep polyclonal Ab, TGN46 (AbD Serotec) were
used as cellular markers. Anti-HA Ab (clone: HA-7; Sigma) and anti-
FLAG Ab (clone: M2; Sigma) were also used. Alexa Fluor 488-
conjugated F(ab’)2 fragment of donkey anti-mouse IgG, Alexa Fluor
488-conjugated donkey anti-sheep IgG, Alexa Fluor 594-conjugated
donkey anti-rabbit IgG (Molecular Probes), and Cy5-conjugated
donkey anti-mouse IgG (Jackson ImmunoResearch Laboratories
Inc) were used as secondary antibodies.Immunoﬂuorescence assay
The indirect immunoﬂuorescence assay (IFA) was performed
as described previously (Akkapaiboon et al., 2004). Speciﬁc
immunoﬂuorescence was observed with a confocal laser-scan-
ning microscope, Leica DMIRE2 (Leica Microsystems).Western blotting
Western blotting was performed as described previously
(Akkapaiboon et al., 2004).
Glycosidase digestion
For endoglycosidase digestion, endoglycosidase H (endo H)
and peptide N-glycosidase (PNGase F) were purchased from New
England Biolabs. The lysates were resuspended in digestion buffer
and digested with endo H or PNGase F as speciﬁed by the
manufacturer.
Plasmid construction
To generate an expression plasmid for N-terminal HA-tagged
HHV-6A gM, primers AgMHAecoRIF and AgMecorIR (shown in
Table 1) were used to amplify inserts from HHV-6A (strain GS)
cDNA. The ﬁnished construct, named HA-AgM, was made by
inserting the PCR products into pCAGGS (Niwa et al., 1991) at
Table 1
Primer sequence.
Primer name Sequence
AgMHAEcoRIF 50-accgaattccacagagctaccatgtacccatacgatgttccagattacgctgcctccagt-30
AgMecorIR 50-accgaattcctaaagtgtcactcgttttcat-30
AgNFMluI 50-accacgcgtaaataacgcttaaatgagttg-30
AgNfragRxhoI 50-accctcgagttacttgtcgtcatcgtctttgtagtcataacccttcaccgtctctgaag-30
AgMFKan 50-gagtatcgttctgaaacctgttctccatcacagagctggtttggcctccagtcgtgtagaagcatgacgacgataagtagggataac-30
AgMRKan 50-gatccgtaaattaatggtgtctacacgactggaggccaaaccagctctgtgatggagaacaaccaattaaccaattctga-30
AgMKanRevF 50-atcgttctgaaacctgttctccatcacagagctggtatggcctccagtcgtgtagaaggatgacgacgataagtaggg-30
AgMKanRevR 50-agatccgtaaattaatggtgtctacacgactggaggccataccagctctgtgatggagaacaaccaattaaccaattctga-30
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C-terminal FLAG-tagged HHV-6A gN, primers AgNfragRxhoI and
AgNFMluI (shown in Table 1) were used to amplify inserts from
HHV-6A (strain GS) cDNA. The completed construct, named
AgN-FLAG, was made by inserting the PCR products into pCAGGS
at the XhoI and MluI restriction sites.Plasmid transfection
293T cells were transfected with expression plasmids using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
instructions.Immunoprecipitation
293T cells cotransfected with plasmids HA-AgM and AgN-
FLAG were lysed in TNE buffer (0.01 M Tris-HCl [pH 7.4], 0.15 M
NaCl, 1 mM EDTA, 1% Nonidet-P-40) for 30 min on ice. After
centrifugation at 200,000 g for 1 h, the supernatants were
incubated with anti-HA Ab- or anti-FLAG Ab-protein G-Sepharose
(GE Healthcare Biosciences) complex at 4 1C for 4 h. The immu-
nocomplexes were washed with TNE buffer to remove unbound
proteins. The precipitated proteins were solubilized with sample
buffer (32 mM Tris-HCl [pH 6.8], 1.5% SDS, 5% glycerol, 2.5%
2-mercapto-ethanol) and separated by SDS-PAGE. The proteins
in the precipitates were detected by western blotting as described
above.Construction of the gM mutant and its revertant
To generate the recombinant virus with a point mutation in
the start codon for gM, we used a two-step Red-mediated
mutagenesis procedure (Adler et al., 2000; Kato et al., 2008;
Tischer et al., 2006) in an E. coli GS1783 strain that harbors
the HHV-6ABAC genome (Tang et al., 2010). The primer pairs
AgMFKan and AgMRKan used for the ampliﬁcation are shown
in Table 1. The recombination using two-step Red-mediated
mutagenesis was performed as described previously (Tang et al.,
2011; Tang et al., 2010). We named the resultant BAC, HHV-
6ABACgMM1L.
To generate the gM revertant, in which the start codon of
gM was repaired, the same procedure used to generate HHV-
6ABACgMM1L was performed, except that GS1783 harboring
HHV-6ABACgMM1L, and the primers AgMKanRevF and AgMKan-
RevR, as shown in Table 1, were used.
The method for generating HHV-6A recombinant viruses was
described previously (Tang et al., 2010). We named the resultant
BAC, HHV-6ABACgMM1Lrev. The detailed method for reconstitut-
ing infectious virus using HHV-6A BACs was described previously
(Tang et al., 2011, 2010).Acknowledgments
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